World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
36
Citations
4601
World Ranking
9604
National Ranking
952

Jesus Perez publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Jesus Perez sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 113 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Jesus Perez D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Jesus Perez sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 36 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Jesus Perez is affiliated with the University of Cambridge in the United Kingdom. Their research primarily spans the fields of Medicine and Psychology, with specific focus on Psychiatry and Mental Health, Clinical Psychology, Experimental and Cognitive Psychology, Social Psychology, and Philosophy.

The main topics covered in their work include schizophrenia research and treatment, mental health research topics, mental health treatment and access, mental health and psychiatry, suicide and self-harm studies, psychosomatic disorders and their treatments, and psychiatric care and mental health services.

Jesus Perez has contributed to multiple publications, with frequent appearances in the following venues:

  • Schizophrenia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Schizophrenia Bulletin
  • Schizophrenia Bulletin Open
  • Translational Psychiatry

Recent papers authored or co-authored by Jesus Perez include:

  • On Dimensionality, Measurement Invariance, and Suitability of Sum Scores for the PHQ-9 and the GAD-7 (2020), published in Assessment
  • Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis (2024), published in Schizophrenia Bulletin
  • Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis (2021), published in The Lancet Psychiatry
  • Exclusion criterion: learning disability (2020), published in The Lancet
  • Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit (2020), published in Schizophrenia Research

Frequent co-authors collaborating with Jesus Perez include:

  • Peter B. Jones
  • Daniel H. Mathalon
  • Matthew R. Broome
  • Rachel Upthegrove
  • Philip McGuire

Best Publications

  • Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification

    Paolo Fusar-Poli;Paolo Fusar-Poli;Marco Cappucciati;Marco Cappucciati;Stefan Borgwardt;Scott W. Woods

  • Shift toward prior knowledge confers a perceptual advantage in early psychosis and psychosis-prone healthy individuals

    Christoph Teufel;Christoph Teufel;Naresh Subramaniam;Veronika Dobler;Veronika Dobler;Jesus Perez;Jesus Perez

  • Laterality effect on emotional faces processing: ALE meta-analysis of evidence.

    Paolo Fusar-Poli;Paolo Fusar-Poli;A. Placentino;F. Carletti;F. Carletti;Paul Allen

  • Mood, anxiety and psychotic phenomena measure a common psychopathological factor

    J. Stochl;G. M. Khandaker;G. Lewis;J. Perez

  • Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial.

    Sagnik Bhattacharyya;Robin Wilson;Elizabeth Appiah-Kusi;Aisling O'Neill

  • Onset-age of bipolar disorders at six international sites.

    R.J. Baldessarini;L. Bolzani;L. Bolzani;N. Cruz;N. Cruz;P.B. Jones;P.B. Jones

  • Morbidity in 303 first-episode bipolar I disorder patients.

    Ross J Baldessarini;Ross J Baldessarini;Paola Salvatore;Paola Salvatore;Hari-Mandir Kaur Khalsa;Priscilla Gebre-Medhin

  • The Epidemiology of First-Episode Psychosis in Early Intervention in Psychosis Services: Findings From the Social Epidemiology of Psychoses in East Anglia [SEPEA] Study.

    James B. Kirkbride;Yasir Hameed;Gayatri Ankireddypalli;Konstantinos Ioannidis

  • Lithium in drinking water and suicide rates across the East of England

    Nikolett Kabacs;Anjum Memon;Thom Obinwa;Jan Stochl

  • Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPS

    P. Fusar-Poli;M. Cappucciati;G. Rutigliano;T. Y. Lee

  • The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people.

    Barbara J. Sahakian;Annette B. Bruhl;Jennifer Cook;Clare Killikelly

  • Ethnic Minority Status, Age-at-Immigration and Psychosis Risk in Rural Environments: Evidence From the SEPEA Study

    James B Kirkbride;James B Kirkbride;Yasir Hameed;Konstantinos Ioannidis;Gayatri Ankireddypalli

  • Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis.

    Christylai Hui;Carmen Morcillo;Debra A. Russo;Jan Štochl

  • Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second Cohort.

    Paul Allen;Matilda Azis;Gemma Modinos;Matthijs G Bossong;Matthijs G Bossong

  • On Dimensionality, Measurement Invariance, and Suitability of Sum Scores for the PHQ-9 and the GAD-7:

    Jan Stochl;Jan Stochl;Jan Stochl;Eiko I Fried;Jessica Fritz;Tim J Croudace

  • Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for Psychosis.

    Matthijs G. Bossong;Matthijs G. Bossong;Mathilde Antoniades;Matilda Azis;Carly Anne Samson

  • Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics.

    Ángel L. Montejo;Celso Arango;Miquel Bernardo;José L. Carrasco

  • Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values

    Akvile Bukenaite;Jan Stochl;Nilufar Mossaheb;Miriam R Schäfer

  • Clinical effectiveness and cost-effectiveness of tailored intensive liaison between primary and secondary care to identify individuals at risk of a first psychotic illness (the LEGs study): a cluster-randomised controlled trial.

    Jesus Perez;Huajie Jin;Debra A Russo;Jan Stochl

  • Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis.

    Robin Paul Wilson;Matthijs G. Bossong;Matthijs G. Bossong;Elizabeth Mary Appiah-Kusi;Natalia Petros

  • Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis

    Gemma Modinos;Fatma Şimşek;Matilda Azis;Matthijs Bossong

  • Multilevel ordinal factor analysis of the positive and negative syndrome scale (PANSS).

    Jan Stochl;Peter B. Jones;James Plaistow;Ulrich Reininghaus

Frequent Co-Authors

Peter Jones
Peter Jones University of Cambridge
Paul Allen
Paul Allen Royal Holloway University of London
Jan Stochl
Jan Stochl University of Cambridge
Philip McGuire
Philip McGuire University of Oxford
Oliver D. Howes
Oliver D. Howes King's College London
James M. Stone
James M. Stone Brighton and Sussex Medical School
James B. Kirkbride
James B. Kirkbride University College London
Anthony A. Grace
Anthony A. Grace University of Pittsburgh
Paolo Fusar-Poli
Paolo Fusar-Poli King's College London
Ross J. Baldessarini
Ross J. Baldessarini Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Psychology opens doors to a variety of rewarding online programs and career paths—one of the most important is substance abuse counseling. Demand for certified counselors is rising across the U.S., making this field both accessible and impactful for psychology graduates.

While a bachelor’s degree may be the minimum for some entry-level positions, most roles in substance abuse counseling require specialized training and certifications. Requirements vary by location; for example, Mesa substance abuse counselors education requirements recommend both a degree and state-approved coursework. Similarly, Miami substance abuse counselors education requirements emphasize fieldwork and ongoing professional development.

Certification is a key step in many cities. In Milwaukee, aspiring counselors must meet Milwaukee substance abuse counselor certification requirements to qualify for state licensure. Meanwhile, Minneapolis substance abuse counselors education requirements stress the importance of accredited online programs and supervised clinical experience.

For those interested in helping others overcome addiction and mental health challenges, pursuing an online psychology degree can be an effective starting point toward a fulfilling counseling career.

Best Scientists Citing Jesus Perez

Trending Scientists